Banner

Omega 3 Prescription Drugs Global Market Report 2023 – By Drug Type (Vascepa, Lovaza, Other Type), By Application Type (Hypertriglyceridemia, Other Application Type), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The omega-3 prescription drug lowers the number of triglycerides (a fat-like substance) in the blood and raises the levels of good cholesterol (HDL) in the body. Omega-3 drugs or fatty acids are nutrients obtained from food (or supplements) that assist in developing and maintaining a healthy body and are critical in constructing every cell wall.

The main drug types of omega-3 prescription drugs include vascepa, lovaza, and other types. The vascepa drug is used in adults to reduce the risk of heart attack, stroke, and certain types of heart problems that necessitate hospitalization. Vascepa is an FDA-approved medication used to reduce the risk of certain cardiovascular problems in adults who have high triglyceride levels and two or more additional risk factors for cardiovascular diseases, such as high blood pressure, high cholesterol, or obesity. The application of omega-3 prescription drugs includes hypertriglyceridemia and other application types. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The omega 3 prescription drugs market research report is one of a series of new reports from The Business Research Company that provides omega 3 prescription drugs market statistics, including omega 3 prescription drugs industry global market size, regional shares, competitors with an omega 3 prescription drugs market share, detailed omega 3 prescription drugs market segments, market trends and opportunities, and any further data you may need to thrive in the omega 3 prescription drugs industry. This omega 3 prescription drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global omega 3 prescription drugs market size is expected to grow from $1.37 billion in 2022 to $1.49 billion in 2023 at a compound annual growth rate (CAGR) of 8.74%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The omega 3 prescription drugs market size is expected to reach $2.09 billion in 2027 at a CAGR of 8.84%.

Rising cases of cardiovascular diseases (CVDs) are expected to contribute to the growth of the omega-3 prescription drug market. Increased blood triglyceride levels (a fatty-like substance) are linked to a higher risk of cardiovascular disorders, and omega-3 supplements aid in regulating and lowering triglyceride levels. For instance, according to the 2021 World Health Organization (WHO) report, an estimated 17.9 million people died from CVDs, accounting for 32% of global deaths. The causes of 85% of these fatalities were heart attacks and strokes. Therefore, rising cases of cardiovascular diseases (CVDs) drive the growth of the omega-3 prescription drug market.

New product innovations have emerged as a key trend gaining popularity in the omega-3 prescription drug market. Major companies operating in the manufacturing of omega-3 drugs are focused on developing new product innovations to strengthen their position in the market. For instance, in October 2022, the European Commission gave the green light to plant-based omega-3 products from DSM for fish and animal substitutes throughout the EU. DSM claims that the product enhances plant-based foods' nutritional profile and enables the development of fish products based on animals that will be similar to current fish products. This omega 3 supplement can be used to enhance the nutritional content of goods without having an adverse effect on the marine ecosystem.

In August 2021, Woodward Pharma Services, a US-based pharmaceutical company, acquired Lovaza (omega-3-acid ethyl esters) capsules from GlaxoSmithKline for an undisclosed amount. With this acquisition, Woodward Pharma will now have the license/authority to use Lovaza capsules in adult patients with severe hypertriglyceridemia (a high level of a certain type of fat (triglycerides) in the blood). Lovaza is a prescription omega-3 product approved by the FDA and is a medical-grade supplement for high triglyceride management. GlaxoSmithKline is a UK-based pharmaceutical and biotechnology company.

Major players in the omega 3 prescription drugs market are Abbott Laboratories, Amarin Pharmaceuticals Ireland Ltd., GSK PLC., Natrapharm Inc., Viatris Inc., Grupo Ferrer International SA, Camber Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Zydus Group, Hikma Pharmaceuticals PLC, KD Pharma Group, and Woodward Pharma Services.

North America was the largest region in the omega 3 prescription drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the omega 3 prescription drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The omega 3 prescription drugs market consists of sales of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global omega 3 prescription drugs market is segmented -

1) By Drug Type: Vascepa, Lovaza, Other Type

2) By Application Type: Hypertriglyceridemia, Other Application Type 

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Table Of Contents

    1. Executive Summary

    2. Omega 3 Prescription Drugs Market Characteristics

    3. Omega 3 Prescription Drugs Market Trends And Strategies

    4. Omega 3 Prescription Drugs Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Omega 3 Prescription Drugs Market

    4.2. Ukraine-Russia War Impact On Omega 3 Prescription Drugs Market

    4.3. Impact Of High Inflation On Omega 3 Prescription Drugs Market

    5. Omega 3 Prescription Drugs Market Size And Growth

    5.1. Global Omega 3 Prescription Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Omega 3 Prescription Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Omega 3 Prescription Drugs Market Segmentation

    6.1. Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Vascepa

    Lovaza

    Other Type

    6.2. Global Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hypertriglyceridemia

    Other Application Type

    6.3. Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    7. Omega 3 Prescription Drugs Market Regional And Country Analysis

    7.1. Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Omega 3 Prescription Drugs Market

    8.1. Asia-Pacific Omega 3 Prescription Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Omega 3 Prescription Drugs Market

    9.1. China Omega 3 Prescription Drugs Market Overview

    9.2. China Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Omega 3 Prescription Drugs Market

    10.1. India Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Omega 3 Prescription Drugs Market

    11.1. Japan Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Omega 3 Prescription Drugs Market

    12.1. Australia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Omega 3 Prescription Drugs Market

    13.1. Indonesia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Omega 3 Prescription Drugs Market

    14.1. South Korea Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Omega 3 Prescription Drugs Market

    15.1. Western Europe Omega 3 Prescription Drugs Market Overview

    15.2. Western Europe Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Omega 3 Prescription Drugs Market

    16.1. UK Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Omega 3 Prescription Drugs Market

    17.1. Germany Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Omega 3 Prescription Drugs Market

    18.4. France Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Omega 3 Prescription Drugs Market

    19.1. Eastern Europe Omega 3 Prescription Drugs Market Overview

    19.2. Eastern Europe Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Omega 3 Prescription Drugs Market

    20.1. Russia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Omega 3 Prescription Drugs Market

    21.1. North America Omega 3 Prescription Drugs Market Overview

    21.2. North America Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Omega 3 Prescription Drugs Market

    22.1. USA Omega 3 Prescription Drugs Market Overview

    22.2. USA Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Omega 3 Prescription Drugs Market

    23.1. South America Omega 3 Prescription Drugs Market Overview

    23.2. South America Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Omega 3 Prescription Drugs Market

    24.1. Brazil Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Omega 3 Prescription Drugs Market

    25.1. Middle East Omega 3 Prescription Drugs Market Overview

    25.2. Middle East Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Omega 3 Prescription Drugs Market

    26.1. Africa Omega 3 Prescription Drugs Market Overview

    26.2. Africa Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Omega 3 Prescription Drugs Market Competitive Landscape And Company Profiles

    27.1. Omega 3 Prescription Drugs Market Competitive Landscape

    27.2. Omega 3 Prescription Drugs Market Company Profiles

    27.2.1. Abbott Laboratories

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Amarin Pharmaceuticals Ireland Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. GSK PLC.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Natrapharm Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Viatris Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Omega 3 Prescription Drugs Market

    29. Omega 3 Prescription Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Abbott Laboratories Financial Performance
  • Table 47: Amarin Pharmaceuticals Ireland Ltd. Financial Performance
  • Table 48: GSK PLC. Financial Performance
  • Table 49: Natrapharm Inc. Financial Performance
  • Table 50: Viatris Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Omega 3 Prescription Drugs Market, Segmentation By Application Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Abbott Laboratories Financial Performance
  • Figure 47: Amarin Pharmaceuticals Ireland Ltd. Financial Performance
  • Figure 48: GSK PLC. Financial Performance
  • Figure 49: Natrapharm Inc. Financial Performance
  • Figure 50: Viatris Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report